(VIANEWS) – NASDAQ Composite ended the session with Pacific Biosciences of California rising 7.5% to $31.39 on Wednesday, after two successive sessions in a row of gains. NASDAQ Composite rose 0.92% to $14,631.95, following the last session’s upward trend on what was a somewhat up trend exchanging session today.

Volume

Today’s last reported volume for Pacific Biosciences of California is 3644660, 48.45% above its average volume of 2455100.

Pacific Biosciences of California’s last close was $29.20, 45.61% below its 52-week high of $53.69.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 75% for the current quarter and 68.3% for the next. The company’s growth estimates for the present quarter and the next is a negative 33.3% and a negative 50%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 85.9%, now sitting on 92.29M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Pacific Biosciences of California’s stock is considered to be oversold (<=20).

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $31.39 at 20:06 EST, way below its 52-week high of $53.69 and way above its 52-week low of $3.57.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s value is above its 50-day moving average of $30.08 and under its 200-day moving average of $31.85.

More news about Pacific Biosciences of California (PACB).

LEAVE A REPLY

Please enter your comment!
Please enter your name here